Reaction Biology is a preclinical oncology CRO offering a comprehensive portfolio of in vivo services for testing of new anti-cancer drugs. Our integrated cancer drug testing platform includes services for all steps of the drug discovery process, supporting the development of your preclinical candidate pipeline.
The premises of our CRO feature a state-of-the-art animal facility is located in Germany. All of our in vivo services are conducted under GV-SOLAS and ISO9001 in regard to standards of animal welfare and code of practice.
You will be guided by an assigned in vivo project manager throughout all phases of the study - layout, protocol, conduction, results. Before, during, and after the study, your project manager will be just one phone call away for any questions you may have. Accountability and reproducibility are the fundaments of the high quality of our in vivo pharmacology.
Our preclinical oncology service portfolio is supplemented by options to assess drug tolerability, PK, and PD in mice.